Protease stabilized acylated insulin analogues
US10259856B2 · kind B2 · utility
1Cited by
46References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2015 |
| Grant date | Apr 16, 2019 |
| Priority date | — |
| Expiry date | Apr 14, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel acylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.